Sana Biotechnology Inc (SANA)
8.715
+0.16
(+1.93%)
USD |
NASDAQ |
May 17, 16:00
8.715
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology 1 Year Total Returns (Daily): 16.71% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 16.71% |
| May 16, 2024 | 18.09% |
| May 15, 2024 | 23.27% |
| May 14, 2024 | 35.01% |
| May 13, 2024 | 24.18% |
| May 10, 2024 | 14.89% |
| May 09, 2024 | 22.75% |
| May 08, 2024 | 71.30% |
| May 07, 2024 | 76.14% |
| May 06, 2024 | 75.44% |
| May 03, 2024 | 89.82% |
| May 02, 2024 | 93.66% |
| May 01, 2024 | 76.05% |
| April 30, 2024 | 70.13% |
| April 29, 2024 | 71.64% |
| April 26, 2024 | 66.73% |
| April 25, 2024 | 61.90% |
| April 24, 2024 | 70.58% |
| April 23, 2024 | 54.39% |
| April 22, 2024 | 51.34% |
| April 19, 2024 | 36.14% |
| April 18, 2024 | 39.28% |
| April 17, 2024 | 46.45% |
| April 16, 2024 | 62.04% |
| April 15, 2024 | 64.74% |
| Date | Value |
|---|---|
| April 12, 2024 | 138.9% |
| April 11, 2024 | 156.4% |
| April 10, 2024 | 174.4% |
| April 09, 2024 | 183.9% |
| April 08, 2024 | 176.3% |
| April 05, 2024 | 178.1% |
| April 04, 2024 | 164.3% |
| April 03, 2024 | 184.5% |
| April 02, 2024 | 169.7% |
| April 01, 2024 | 209.5% |
| March 28, 2024 | 219.5% |
| March 27, 2024 | 199.4% |
| March 26, 2024 | 192.9% |
| March 25, 2024 | 181.4% |
| March 22, 2024 | 179.8% |
| March 21, 2024 | 161.4% |
| March 20, 2024 | 154.3% |
| March 19, 2024 | 147.1% |
| March 18, 2024 | 154.6% |
| March 15, 2024 | 159.6% |
| March 14, 2024 | 163.1% |
| March 13, 2024 | 182.2% |
| March 12, 2024 | 193.4% |
| March 11, 2024 | 200.6% |
| March 08, 2024 | 164.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.98%
Minimum
Feb 11 2022
219.5%
Maximum
Mar 28 2024
-23.61%
Average
-42.20%
Median
1 Year Total Returns (Daily) Benchmarks
| Rocket Pharmaceuticals Inc | 4.92% |
| Solid Biosciences Inc | 45.53% |
| Dyne Therapeutics Inc | 104.0% |
| Taysha Gene Therapies Inc | 357.8% |
| Tenaya Therapeutics Inc | -34.83% |